VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MBIMBIA Inc.
$6.51$332M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMBIFinancials

MBIA Inc. (MBI) Financials

30Y historyFree accessUpdated daily

The company continues to struggle with severe margin compression, evidenced by a net margin of -221.25% and a 2026Q1 operating loss of $41 million.

MBI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue90M80M42M7M154M159M282M281M159M405M289M854M1.26B1.15B2.39B-1.58B834M2.69B-856.6M-283.86M2.7B2.3B2.07B1.47B618M1.14B1.06B444M912M766.1M630.9M
Revenue Growth %109.3%90.48%500%-95.45%-3.14%-43.62%0.36%76.73%-60.74%40.14%-66.16%-32.38%10.02%-51.89%250.73%-289.81%-68.94%413.45%-201.77%-110.5%17.73%11.06%40.57%137.99%-45.82%7.88%138.17%-51.32%19.04%21.43%36.49%
Medical Costs & Claims56M68M188M182M46M356M540M253M83M706M260M173M177M163M100M-17M291M946M1.32B967.22M146.9M150.85M149.29M134.91M109.36M99.08M87.27M235.15M69.28M53.57M45.33M
Medical Cost Ratio %62.22%85%447.62%2600%29.87%223.9%191.49%90.04%52.2%174.32%89.97%20.26%14.01%14.2%4.19%1.07%34.89%35.23%-153.86%-340.74%5.43%6.57%7.22%9.17%17.7%8.69%8.25%52.96%7.6%6.99%7.19%
Gross Profit34M12M-146M-175M108M-197M-258M28M76M-301M29M681M1.09B985M2.29B-1.57B543M1.74B-2.17B-1.25B2.56B2.15B1.92B1.34B508.64M1.04B970.19M208.85M842.72M712.53M585.57M
Gross Margin %37.78%15%-347.62%-2500%70.13%-123.9%-91.49%9.96%47.8%-74.32%10.03%79.74%85.99%85.8%95.81%98.93%65.11%64.77%253.86%440.74%94.57%93.43%92.78%90.83%82.3%91.31%91.75%47.04%92.4%93.01%92.81%
Gross Profit Growth %-108.22%16.57%-262.04%154.82%23.64%-1021.43%-63.16%125.25%-1137.93%-95.74%-37.29%10.25%-56.91%245.98%-388.4%-68.78%179.97%-73.82%-148.94%19.16%11.83%43.59%162.64%-51.17%7.37%364.55%-75.22%18.27%21.68%36.08%
Operating Expenses194M193M295M309M256M248M320M385M372M360M368M392M445M569M688M673M638M522M1.55B1.81B1.42B1.13B747.28M173.9M-279.36M-864.08M287.19M-154.15M360.72M19.93M19.37M
OpEx / Revenue %215.56%241.25%702.38%4414.29%166.23%155.97%113.48%137.01%233.96%88.89%127.34%45.9%35.23%49.56%28.83%-42.51%76.5%19.44%-181.27%-639.26%52.65%49.13%36.14%11.82%-45.2%-75.75%27.16%-34.72%39.55%2.6%3.07%
Depreciation & Amortization000000000000000-1M-15M-50M9.64M10.16M8.64M11.5M63.33M15.5M14.05M16.61M-13.12M18.35M-5.5M-6.2M-9.6M
Combined Ratio %277.78%326.25%1150%7014.29%196.1%379.87%304.96%227.05%286.16%263.21%217.3%66.16%49.25%63.76%33.03%-41.44%111.39%54.67%-335.14%-979.99%58.08%55.7%43.36%21%-27.51%-67.06%35.41%18.24%47.15%9.59%10.26%
Operating Income-160M-181M-441M-484M-148M-445M-578M-357M-296M-661M-339M289M641M416M1.6B-2.24B-95M1.22B-3.73B-3.07B1.13B1.02B1.17B1.16B788M1.91B683M363M482M692.6M566.2M
Operating Margin %-177.78%-226.25%-1050%-6914.29%-96.1%-279.87%-204.96%-127.05%-186.16%-163.21%-117.3%33.84%50.75%36.24%66.97%141.44%-11.39%45.33%435.14%1079.99%41.92%44.3%56.64%79%127.51%167.06%64.59%81.76%52.85%90.41%89.74%
Operating Income Growth %-58.96%8.88%-227.03%66.74%23.01%-61.9%-20.61%55.22%-94.99%-217.3%-54.91%54.09%-73.97%171.37%-2256.84%-107.81%132.65%-21.58%-370.52%11.41%-13.14%0.77%47.46%-58.65%179.03%88.15%-24.69%-30.41%22.32%64.1%
EBITDA34M16M-232M-273M32M-264M-350M-74M-3M-389M-117M527M890M697M1.94B-2.24B-110M1.17B-3.72B-3.06B1.14B1.03B1.23B1.18B802.05M1.92B669.88M381.35M476.5M686.4M556.6M
EBITDA Margin %37.78%20%-552.38%-3900%20.78%-166.04%-124.11%-26.33%-1.89%-96.05%-40.48%61.71%70.47%60.71%81.18%141.5%-13.19%43.46%434.01%1076.42%42.24%44.8%59.7%80.06%129.78%168.52%63.35%85.89%52.25%89.6%88.22%
Interest Expense295M197M209M211M180M181M228M283M293M272M222M238M249M281M339M362M384M475M1.17B1.58B1.18B822.24M522M400M58.45M56.45M53.76M53.94M44.6M38.6M34.7M
Non-Operating Income-194M-197M-209M-211M-180M-181M-228M-283M-293M-272M-222M-238M-249M-281M-339M-362M-384M-475M-1.17B-1.58B-1.18B-822.24M-522M-400M-63.03M1.06B-53.76M-78.82M-44.6M654M531.5M
Pretax Income-160M-181M-441M-484M-148M-445M-578M-357M-296M-661M-339M289M641M416M1.6B-2.24B-95M1.22B-3.73B-3.07B1.13B1.02B1.17B1.16B788M765M683M363M482M525.2M448.4M
Pretax Margin %-177.78%-226.25%-1050%-6914.29%-96.1%-279.87%-204.96%-127.05%-186.16%-163.21%-117.3%33.84%50.75%36.24%66.97%141.44%-11.39%45.33%435.14%1079.99%41.92%44.3%56.64%79%127.51%67.06%64.59%81.76%52.85%68.56%71.07%
Income Tax-4M0001M002M0944M-1M109M72M166M364M-920M-148M583M-1.05B-1.14B320.08M304.19M317.19M335.06M205.76M207.83M186.22M67.35M132.3M119.6M100.7M
Effective Tax Rate %2.5%0%0%0%-0.68%0%0%-0.56%0%-142.81%0.29%37.72%11.23%39.9%22.78%41.09%155.79%47.9%28.3%37.31%28.24%29.9%27.09%28.83%26.11%27.17%27.27%18.55%27.45%22.77%22.46%
Net Income-155M-177M-444M-487M-203M-445M-578M-359M-296M-1.6B-338M180M569M250M1.23B-1.32B53M634M-2.67B-1.92B819.29M710.99M843M825M585M570M525M315M386M405.6M347.7M
Net Margin %-172.22%-221.25%-1057.14%-6957.14%-131.82%-279.87%-204.96%-127.76%-186.16%-396.3%-116.96%21.08%45.05%21.78%51.72%83.32%6.35%23.61%312.01%677.07%30.31%30.96%40.77%56.09%94.66%49.97%49.65%70.95%42.32%52.94%55.11%
Net Income Growth %63.18%60.14%8.83%-139.9%54.38%23.01%-61%-21.28%81.56%-374.85%-287.78%-68.37%127.6%-79.74%193.56%-2588.68%-91.64%123.72%-39.06%-334.59%15.23%-15.66%2.18%41.03%2.63%8.57%66.67%-18.39%-4.83%16.65%28.1%
EPS (Diluted)-3.11-3.59-9.42-10.19-3.92-8.99-9.78-4.43-3.33-13.50-2.541.062.761.296.33-6.850.262.99-12.11-15.175.995.185.825.693.963.813.532.092.571.830.80
EPS Growth %64.66%61.89%7.56%-159.95%56.4%8.08%-120.77%-33.03%75.33%-431.5%-339.62%-61.59%113.95%-79.62%192.41%-2734.62%-91.3%124.69%20.17%-353.26%15.64%-11%2.28%43.69%3.94%7.93%68.9%-18.68%40.44%128.75%-62.62%
EPS (Basic)--3.59-9.42-10.19-3.92-8.99-9.78-4.43-3.33-13.50-2.541.062.941.306.36-6.850.262.99-12.11-15.176.175.305.945.753.993.843.552.112.601.860.82
Diluted Shares Outstanding49.8M49.28M47.44M48.21M49.8M49.47M59.07M81.01M89.01M118.93M133M164.87M190.9M190.31M189.9M192.51M203.02M208.16M220.79M126.67M136.69M137.22M144.85M144.99M147.73M149.61M148.73M150.72M150.19M134.12M129.82M

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Legacy portfolio credit deterioration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Underwriting Profitability Deficits

As reported in recent financial statements, MBI continues to struggle with severe margin compression, evidenced by a net margin of -221.25% and a volatile loss ratio that reached 64.3% in 2025Q1, suggesting that the company's core insurance operations remain fundamentally unable to cover their own administrative overhead.

The company's inability to achieve a sustainable combined ratio below 100% highlights the structural challenges of managing a run-off portfolio where fixed costs remain high while the premium base continues to erode. Investors should monitor whether the recurring negative operating income is a result of long-term liability provisioning or simply an unsustainable cost structure that exceeds the diminishing revenue stream.

Volatile Revenue Amid Run-off

Based on reported figures, MBI's revenue trajectory appears highly erratic, with a 90.48% headline growth rate that likely masks underlying instability, as the company lacks the new business production necessary to offset the natural decay of its legacy municipal bond insurance contracts over the long term.

The extreme fluctuations in quarterly revenue suggest that the top line is driven more by non-recurring legal settlements and accounting adjustments than by core insurance activity. This lack of predictable premium growth reinforces the view that the company is effectively a liquidating entity rather than a going concern capable of organic expansion.

Reserve Volatility Masks Underlying Risk

According to recent SEC filings, the company's loss and loss adjustment expenses have shown significant swings, including a $99 million charge in 2025Q4, which indicates that the adequacy of existing reserves remains a primary source of uncertainty for the firm's remaining capital base and future solvency.

The frequent adjustments to loss reserves suggest that the company is still grappling with the tail risk of its legacy municipal exposures. Analysts should remain cautious, as these lumpy reserve movements may continue to obscure the true economic health of the National subsidiary and its capacity to upstream dividends to the parent.

Structural Challenges to Capital Recovery

While management emphasizes de-risking, the persistent negative operating income, as shown in the 2026Q1 data with a $41 million operating loss, suggests that the cost of maintaining the run-off infrastructure may be eroding the very capital that shareholders expect to be returned through future distributions.

The market's valuation of MBI as a potential source of capital returns may be overly optimistic if the legal and administrative costs of the run-off continue to outpace the cash generated by the insured portfolio. Investors should investigate whether the current pace of capital depletion is sustainable or if it threatens the long-term viability of the parent company's balance sheet.

MBI — Frequently Asked Questions

Quick answers to the most common questions about buying MBI stock.

What was MBIA Inc.'s (MBI) revenue in 2025?

For fiscal year 2025, MBIA Inc. (MBI) reported total revenue of $80.0M. This represents a 87.3% decline compared to $630.9M in 1996.

Is MBIA Inc. (MBI) profitable?

MBIA Inc. (MBI) reported a net loss of $177.0M for the fiscal year ending 2025.

What is MBIA Inc.'s operating profit margin?

MBIA Inc. (MBI) reported an operating income of $-181.0M, resulting in an operating profit margin of -226.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is MBIA Inc.'s gross profit and gross margin?

MBIA Inc. (MBI) generated $12.0M in gross profit for the year, representing a gross profit margin of 15.0%. This demonstrates the company's core pricing power and production efficiency.